HedgeChatter

  • Home /
  • Tag Archives

PLX

Protalix BioTherapeutics Signs Clinical Development Agreement With Pfizer for ELELYSO(TM) (taliglucerase alfa)

[at noodls] – CARMIEL, Israel, Dec. 6, 2012 (GLOBE NEWSWIRE) — Protalix BioTherapeutics, Inc. (NYSE-MKT:PLX) (TASE:PLX), announced today that it has entered into a Clinical Development Agreement with Pfizer Inc. under … moreView todays social media effects on PLXView the latest stocks trending across Twitter. Click to view dashboardSee who Protalix is hiring next, click here to view […]

December 6, 2012 Bystocknews , Comments Off on Protalix BioTherapeutics Signs Clinical Development Agreement With Pfizer for ELELYSO(TM) (taliglucerase alfa) read more

Protalix BioTherapeutics to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York City

[at noodls] – CARMIEL, Israel, Dec. 5, 2012 (GLOBE NEWSWIRE) — Protalix BioTherapeutics, Inc. (NYSE-MKT:PLX) (TASE:PLX), today announced that Yossi Maimon, the Company’s Vice President and Chief Financial Officer, … moreView todays social media effects on PLXView the latest stocks trending across Twitter. Click to view dashboardSee who Protalix is hiring next, click here to view […]

December 5, 2012 Bystocknews , Comments Off on Protalix BioTherapeutics to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York City read more

Protalix BioTherapeutics to Present at the 2012 Jefferies Global Healthcare Conference in London

[at noodls] – CARMIEL, Israel, Nov. 8, 2012 (GLOBE NEWSWIRE) — Protalix BioTherapeutics, Inc. (NYSE:PLX) (TASE:PLX), today announced that Yossi Maimon, the Company’s Vice President and Chief Financial Officer, will … moreView todays social media effects on PLXView the latest stocks trending across Twitter. Click to view dashboard […]

November 8, 2012 Bystocknews , Comments Off on Protalix BioTherapeutics to Present at the 2012 Jefferies Global Healthcare Conference in London read more

European Commission Issues Decision on Taliglucerase Alfa Marketing Authorization Application

[at noodls] – NEW YORK and CARMIEL, Israel, Nov. 1, 2012 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE:PFE) and Protalix BioTherapeutics, Inc. (NYSE-MKT:PLX, TASE:PLX) today announced that the European Commission (EC) has issued … moreView todays social media effects on PLXView the latest stocks trending across Twitter. Click to view dashboard […]

November 1, 2012 Bystocknews , Comments Off on European Commission Issues Decision on Taliglucerase Alfa Marketing Authorization Application read more